STANO 50 - Onyx Pharma

Introduced under the name Winstrol in 1962, Stanozolol was originally created by Winthrop Laboratories and later marketed through Sterling in the U.S. Unlike testosterone-based compounds, it did not aromatize and maintained a high anabolic-to-androgenic ratio. Its therapeutic applications ranged from chronic weight loss to bone diseases. Eventually delisted from U.S. markets, it remains in legal circulation in parts of Europe and Latin America. Its reputation in both clinical and performance domains secured its legacy despite shifting regulatory landscapes.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about STANO 50 by Onyx Pharma, consult with your doctor or healthcare professional.